Doctor's Guide to Medical & Other News


To print: Select File and then Print from your browser's menu
---------------------------------------------------------------------------------------
Title: Anti-Hypertensive Biprel (Perindopril Erbumine/Indapamide) Now Available In Canada
URL: http://www.pslgroup.com/dg/2298A2.htm
Doctor's Guide
January 17, 2003


MONTREAL, QC -- January 17, 2003 -- Servier Canada Inc. is pleased to announce that New (pR) Biprel® (perindopril erbumine 4 mg/ indapamide 1.25 mg) is now available in Canada. Biprel is the only combination anti-hypertensive offering the benefits of both Coversyl® and Lozide®. A once-daily fixed- dose tablet, Biprel combines the benefits of an ACE Inhibitor with a diuretic which act synergistically for excellent blood pressure control.(1,2) Biprel is indicated for the treatment of mild to moderate essential hypertension in patients for whom combination therapy is appropriate.

According to the Heart and Stroke Foundation, one out of five Canadians has high blood pressure.(3) And almost two-thirds of patients require multiple treatment agents to achieve blood pressure control.(4) Biprel is an important new treatment option that offers the benefits of a two-in-one tablet and provides patients with a new choice to help manage their hypertension more effectively both from a compliance and cost perspective.

In a recent multi-center, randomized, double-blind, parallel-group study, Biprel was shown to be equally as effective as the combination of enalapril 20mg/hydrochlorothiazide 12.5 mg with reductions of diastolic blood pressure of -13.1 mmHg and -14.2mmHg respectively.(2)

ACE Inhibitors and Diuretics

Despite what some Canadians may think, high blood pressure gives almost no warnings. In fact, close to half the people who have it don't know they do. When high blood pressure is left untreated, it can lead to heart disease, stroke and kidney disease.

ACE inhibitors belong to a family of drugs known as "vasodilators". Vasodilators help the blood vessels to relax and dilate (open up). By relaxing the blood vessels, ACE inhibitors reduce blood pressure and decrease the effort and workload of the heart.

Diuretics (commonly known as "water pills") work on the kidneys to produce more urine. By decreasing water and salt in the body, they lower blood pressure and help reduce the workload on the heart.

Servier Canada Inc. is a pharmaceutical company located in Laval, Quebec that focuses on the development of therapies to treat cardiovascular, metabolic and CNS diseases. In the cardiovascular sector, Servier research has acquired unrivalled experience and international renown. Servier is the only company in the world to deploy a modern and extensive range of cardiovascular products all derived from its own research.

References:
(1)Myers MG, Asmar R, Leenen FHH et al. Fixed low-dose combination therapy in hypertension - a dose response study of perindopril and indapamide. Journal of Hypertension 2000; Vol 18(3):317-325.
(2)Luccioni R, Sever PS, Di Perri T et al. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. Journal of Hypertension 1995, Vol 13:1847-1851.
(3)Heart and stroke Foundation online: http://www.heartandstroke.ca
(4)Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998; 351:1755-62.

SOURCE: Servier Canada Inc.,

---------------------------------------------------------------------------------------------
Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.
---------------------------------------------------------------------------------------------
This news story was printed from *Doctor's Guide to the Internet*
located at http://www.docguide.com
---------------------------------------------------------------------------------------

Return to News Story Page

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.
All contents Copyright (c) 1998 P\S\L Consulting Group Inc.
All rights reserved.